Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Early Nutrition and Heart Structure and Function in Preterm Infants During the First Year of Life

4. November 2026 aktualisiert von: Ahmed Elhady Ragaey Mahmoud, Assiut University

Study the Association of Early Nutritional Exposure With Cardiac Structure and Function in Preterm Infants During the First Year of Life: A Prospective Study

Preterm infants are babies born before 37 completed weeks of pregnancy. Early nutrition is important for their growth and development, and it may also be associated with how their heart develops and functions during infancy.

This prospective observational study aims to investigate the association between early nutritional exposure during the neonatal period and cardiac structure and function at 12 months of corrected age in preterm infants. The study will be conducted at Assiut University Hospital and El-Eman General Hospital in Assiut, Egypt.

Preterm infants born before 37 weeks of gestation who are admitted to the neonatal unit within 24 hours of birth, have adequate records of their nutritional intake, and whose parents provide written informed consent will be considered for participation. Infants with major congenital heart disease, known congenital cardiomyopathy, major genetic or chromosomal abnormalities, or other specified exclusion criteria will not be included.

The study will collect information about maternal and neonatal characteristics, neonatal complications, feeding patterns, growth, and anthropometric measurements. Cardiac structure and function will be assessed using echocardiography at birth, 6 months, and approximately 12 months of corrected age. Growth measurements will also be recorded at different time points, including 12 months of corrected age.

The study will compare cardiac measurements and growth outcomes among infants with different early nutritional exposures. It will also investigate which early nutritional and clinical factors are associated with left ventricular mass index at 12 months of corrected age.

The findings may improve understanding of the relationship between early nutrition and cardiovascular development in preterm infants. Participation will involve clinical data collection, growth measurements, and echocardiographic assessments, with written informed consent obtained from parents or legal guardians.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

This prospective observational study will investigate the association between early nutritional exposure during the neonatal period and cardiac structure and function during the first year of life in preterm infants.

**Study Setting and Population**

The study will be conducted at the Department of Pediatric Medicine, Assiut University Hospital and El-Eman General Hospital, Assiut, Egypt. The study population will include preterm infants born before 37 completed weeks of gestation who are admitted to the neonatal unit within 24 hours of birth, have adequate nutritional records, and whose parents provide written informed consent. Infants must be available for follow-up echocardiographic assessment at 12 months of corrected age.

**Eligibility Criteria**

Infants with major congenital heart disease, known congenital cardiomyopathy, major chromosomal or genetic abnormalities, congenital anomalies, or infections associated with or potentially affecting cardiac disease will be excluded. Infants with inadequate nutritional records, those whose parents refuse written consent, and those without follow-up at one year will also be excluded.

**Nutritional Exposure Groups**

The protocol describes the following feeding groups:

  1. Preterm infants receiving early complementary feeding at 17 weeks.
  2. Preterm infants receiving late complementary feeding after 26 weeks.
  3. Preterm infants receiving breastfeeding.
  4. Preterm infants receiving artificial feeding.
  5. Preterm infants receiving both breast milk and artificial feeding.

Nutritional exposure will be evaluated in relation to cardiac and growth outcomes. The final operational definitions and classification of feeding groups will follow the study protocol.

**Data Collection**

Maternal information will include maternal age, parity, mode of conception, obstetric history and complications, antenatal corticosteroid and magnesium sulfate administration, and mode of delivery.

Neonatal information will include sex, gestational age, singleton or multiple birth, birth weight, length, head circumference, small-for-gestational-age, appropriate-for-gestational-age or large-for-gestational-age classification, Apgar scores, and resuscitation requirements. Neonatal complications will include respiratory distress syndrome, surfactant use, duration of ventilation, and length of hospital stay.

Anthropometric measurements, including weight, length, and head circumference, will be recorded at birth, 36 weeks of postmenstrual age, hospital discharge, and 12 months of corrected age. Appropriate growth z-scores will be calculated using relevant reference standards.

**Echocardiographic Assessment**

Echocardiography will be performed at birth, 6 months, and approximately 12 months of corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group.

Cardiac structural measurements will include left ventricular end-diastolic and end-systolic dimensions, septal and posterior wall thickness, left ventricular mass index, relative wall thickness, left ventricular sphericity index, left atrial size, right ventricular basal dimension, and aortic root dimensions.

Cardiac functional measurements will include left ventricular ejection fraction and global longitudinal strain; mitral E/A ratio, septal and lateral e', E/e' ratio, and isovolumetric relaxation time; tricuspid annular plane systolic excursion, tricuspid S', right ventricular fractional area change, right ventricular free-wall strain, pulmonary acceleration time, and septal configuration. Patent foramen ovale and patent ductus arteriosus, if identified, will be documented as incidental findings.

**Study Outcomes and Statistical Analysis**

The primary objective is to investigate the association between early nutritional strategies and cardiac structure and function at 12 months of corrected age.

Secondary objectives include comparing left ventricular mass index z-scores, other echocardiographic parameters, and anthropometric outcomes among feeding groups, and developing a predictive model to identify early nutritional and clinical factors associated with left ventricular mass index at 12 months.

Data will be analyzed using the Statistical Package for the Social Sciences (SPSS). Continuous variables will be summarized as mean ± standard deviation or median and interquartile range, as appropriate. Categorical variables will be presented as frequencies and percentages. Comparisons will use one-way analysis of variance or the Kruskal-Wallis test, with appropriate post hoc correction, and the chi-square test or Fisher's exact test for categorical variables. Multivariable linear regression will be used for the predictive model. A p-value below 0.05 will be considered statistically significant.

Written informed consent will be obtained from parents or legal guardians, and participant information will be handled confidentially by the research team.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

80

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

1 Jahr bis 1 Jahr (Kind)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Preterm infants at 1 year old age with past nutritional history avalible

Beschreibung

Inclusion Criteria:

  • Preterm infants born at <37 weeks of gestation.
  • preterm Infants admitted to the neonatal unit within 24 hours of birth.
  • preterm Infants who have adequate records of nutritional intake during the neonatal period.
  • Parents provided a consent for participation.
  • preterm Infants available for follow-up echocardiographic assessment at 12 months corrected age.

Exclusion Criteria:

  • preterm Infants with major congenital heart disease or known congenital cardiomyopathy.
  • preterm Infants with major chromosomal, genetic abnormalities, congenital anomaly, or infections associated with or have potential for cardiac disease.
  • Inadequate nutritional records.
  • Refusal to provide written consent.
  • Lack of follow-up at one year.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: COHORT
  • Zeitperspektiven: PROSPECTIVE

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
- Group 1: Includes preterm Infants how receive early complementary feeding at 17 weeks.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 2: includes preterm infants how receive late complementary feeding After 26 weeks.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 3: includes preterm infants how receive breast feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
-Group 4: includes preterm infants who receive artificial feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 5: includes preterm infants who receive both breast and artificial feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
to investigate the association between early nutritional strategies and cardiac structure and function at 12 months of corrected age.
Zeitfenster: one year old age of preterm infants
one year old age of preterm infants

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
comparing left ventricular mass index z-scores, other echocardiographic parameters, and anthropometric outcomes among feeding groups
Zeitfenster: over one year period study
over one year period study

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Dezember 2026

Primärer Abschluss (Geschätzt)

1. Dezember 2027

Studienabschluss (Geschätzt)

30. Dezember 2027

Studienanmeldedaten

Zuerst eingereicht

17. Oktober 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

17. Oktober 2026

Zuerst gepostet (Tatsächlich)

23. Oktober 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

4. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • EarlyNutritionCardiac2025

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .